The outcome of HIV-positive late presenters according to detectable CMV DNA and anti-CMV treatment.

MLA

Bigliano, Paolo, et al. “The Outcome of HIV-Positive Late Presenters According to Detectable CMV DNA and Anti-CMV Treatment.” Antiviral Therapy, vol. 23, no. 5, 2018, pp. 451–56. EBSCOhost, https://doi.org/10.3851/IMP3221.

APA

Bigliano, P., Calcagno, A., Lucchini, A., Audagnotto, S., Montrucchio, C., Marinaro, L., Alcantarini, C., Ghisetti, V., Di Perri, G., & Bonora, S. (2018). The outcome of HIV-positive late presenters according to detectable CMV DNA and anti-CMV treatment. Antiviral Therapy, 23(5), 451–456. https://doi.org/10.3851/IMP3221

Chicago

Bigliano, Paolo, Andrea Calcagno, Anna Lucchini, Sabrina Audagnotto, Chiara Montrucchio, Letizia Marinaro, Chiara Alcantarini, Valeria Ghisetti, Giovanni Di Perri, and Stefano Bonora. 2018. “The Outcome of HIV-Positive Late Presenters According to Detectable CMV DNA and Anti-CMV Treatment.” Antiviral Therapy 23 (5): 451–56. doi:10.3851/IMP3221.